AXIOMPHARMACEUTICALS
AXIOMPHARMACEUTICALS
Account
Comparisons

Repair research

TB-500 vs KPV

Thymosin fragment biology beside anti-inflammatory tripeptide research.

TB-500 (Thymosin Beta-4 Fragment)KPVCatalogue

Overview

This comparison separates TB-500 and KPV for laboratory reference—not product selection.

TB-500: A synthetic 7-amino acid fragment corresponding to the actin-binding region of thymosin beta-4, originally developed for equine use with retained tissue repair properties. TB-500 a…

KPV: KPV is a potent anti-inflammatory tripeptide derived from the C-terminal of alpha-MSH. It exhibits remarkable anti-inflammatory and antimicrobial properties without the pigmentatio…

Key differences

  • Both appear in Tissue repair & recovery literature, but mechanistic framing differs.
  • The useful distinction is research question and receptor context—not relative potency or practical ranking.

Mechanistic differences

TB-500: A synthetic 7-amino acid fragment corresponding to the actin-binding region of thymosin beta-4, originally developed for equine use with retained tissue repair…

KPV: KPV is a potent anti-inflammatory tripeptide derived from the C-terminal of alpha-MSH. It exhibits remarkable anti-inflammatory and antimicrobial properties wit…

Pharmacology

TB-500: Pharmacokinetic detail should be read from primary literature.

KPV: Pharmacokinetic detail should be read from primary literature.

Research focus

TB-500: Tissue repair & recovery: A synthetic 7-amino acid fragment corresponding to the actin-binding region of thymosin beta-4, originally developed for equine use with retaine…

KPV: Tissue repair & recovery: KPV is a potent anti-inflammatory tripeptide derived from the C-terminal of alpha-MSH. It exhibits remarkable anti-inflammatory and antimicrobia…

At a glance

DimensionTB-500KPV
MechanismA synthetic 7-amino acid fragment corresponding to the actin-binding region of thymosin beta-4, originally developed for equine use with retained tiss…KPV is a potent anti-inflammatory tripeptide derived from the C-terminal of alpha-MSH. It exhibits remarkable anti-inflammatory and antimicrobial prop…
Research focusTissue repair & recovery: A synthetic 7-amino acid fragment corresponding to the actin-binding region of thymosin beta-4, originally developed for equine use with retaine…Tissue repair & recovery: KPV is a potent anti-inflammatory tripeptide derived from the C-terminal of alpha-MSH. It exhibits remarkable anti-inflammatory and antimicrobia…
PharmacologyPharmacokinetic detail should be read from primary literature.Pharmacokinetic detail should be read from primary literature.
Receptor / targetSee primary literature.See primary literature.

Practical differentiation

  • AXIOM does not provide dosing, administration, or protocol guidance.
  • Catalogue links appear only where AXIOM lists a research-use product.
  • Reference-only compounds remain comparison terms without implying availability.

References

FAQ

Does this page recommend TB-500 or KPV?

No. It is an editorial comparison for research context only.

Does AXIOM provide protocol guidance?

No. Protocol and dosing decisions belong with qualified laboratory teams and source literature.